Emergency spacers vs. traditional spacers for asthma
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether an emergency-use spacer works as well as a traditional spacer for delivering asthma medication through an inhaler. It may help people with mild to moderate asthma breathe better during an attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 and 80 years old.
- Your asthma should be mild or moderate (not severe).
- You cannot have ischemic heart disease (reduced blood flow to the heart).
- You cannot have had recent abdominal surgery.
- You must be able to do a breathing test (pulmonary function test) correctly.
- You cannot have liver or kidney problems, or be allergic to salbutamol (a common asthma rescue inhaler).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a spacer with your inhaler can lower the risk of serious flare-ups for people over 65 who have COPD or asthma and are already on triple therapy.
This trial tests if a smart spacer can help people with severe asthma use their inhaler correctly and stick to their medication schedule. It’s for adults already taking biologic drugs for asthma.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Asthmatic Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.